Fannin Innovation’s Managing Partner discusses strategies, challenges in biotech investment, and what sets Fannin’s model apart in the industry.

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

Plus: How AI can help cancer patients avoid unnecessary chemotherapies and make it easier to understand your dental X-rays.

Chicago, IL – Ellis Bio, a new biotech company spun out from The University of Chicago, officially launches this week with a mission to revolutionize epigenomics research. Founded by Professor Chuan ...

The Patent Eligibility and Restoration Act (PERA) would remove the current court-imposed restrictions on patent eligibility.

Dr Olale's leadership at MedGenome will accelerate the company’s transformation into the preferred partner for academic institutions, biopharma, and biotech companies seeking advanced multiomic and ...

I-Mab (the "Company"), a U.S.-based, global biotech company exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that Sean ...

New Commons report wisely recommends blacklisting the Wuhan Institute of Virology and its researchers from receiving Canadian ...

There’s no question we’ll keep finding really, really interesting biology in these vents. I can’t stress enough that this was ...

Relying less on animal testing for new drugs and more on lab-made “organoids” designed to mimic the functions of human organs ...

In a series of recent columns, I outlined some of the amazing things happening in northwest Arkansas. Residents of our state have been following the economic boom in the region for decades, but never ...

Sam Altman is an American investor and technology entrepreneur who is currently the CEO of OpenAI and has other companies ...